Skip to main content
null
prnano
  • Menu
  • Articles
    • Case study
    • Communication
    • Editorial
    • Editorial Policies
    • Expression of concern
    • Letters to the Editor
    • Perspective, Opinion, or Discussion
    • Research Article
    • Review
    • Technical Note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • The Rising Talents List
  • Journal Policies
  • search
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:32354/feed
ISSN 2639-9431
Perspective, Opinion, or Discussion
Vol. 3, Issue 2, 2020June 27, 2020 EDT

Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products

Blanka Halamoda-Kenzaoui, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, Susanne Bremer-Hoffmann,
terminologyregulatory challengesfollow-on medicinal productsnanosimilarsregulatory frameworknanomedical devicesnanomedicines
Copyright Logoccby-nc-sa-4.0 • https://doi.org/10.33218/001c.13521
prnano
Halamoda-Kenzaoui, Blanka, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, and Susanne Bremer-Hoffmann. 2020. “Launching Stakeholder Discussions on Identified Regulatory Needs for Nanotechnology-Enabled Health Products.” Precision Nanomedicine 3 (2): 608–21. https:/​/​doi.org/​10.33218/​001c.13521.

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

cookies
cookies
cookies
Powered by Scholastica, the modern academic journal management system